Hematology Testing - Cost Per Reportable Result
ID: W9114F-25-Q-0024Type: Presolicitation
Overview

Buyer

DEPT OF DEFENSEDEPT OF THE ARMYW40M MRCO EUROPEAPO, AE, 09180-0402, USA

NAICS

In-Vitro Diagnostic Substance Manufacturing (325413)

PSC

IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS (6550)

Original Source

https://sam.gov/opp/972b1be114c44bfda7a5324e195fb99e/view
Timeline
    Description

    The Department of Defense, specifically the Department of the Army, is seeking proposals for hematology testing services under a contract titled "Hematology Testing - Cost Per Reportable Result." The objective of this procurement is to obtain in-vitro diagnostic substances, reagents, test kits, and sets to support medical testing operations in Vicenza, Italy. These services are crucial for ensuring accurate and timely hematological assessments, which are vital for patient care and military readiness. Interested vendors should contact Elena Raspitha at elena.m.raspitha.civ@health.mil or by phone at 49637194644669 for further details regarding the presolicitation notice.

    Point(s) of Contact
    Elena Raspitha
    49637194644669
    elena.m.raspitha.civ@health.mil
    Files
    No associated files provided.
    Lifecycle
    Title
    Type
    Hematology Testing - Cost Per Reportable Result
    Currently viewing
    Presolicitation
    Similar Opportunities
    Hematology Testing - Cost Per Reportable Result
    Buyer not available
    The Department of Defense, specifically the U.S. Army, is soliciting proposals for an automated hematology analyzer system to be delivered to the U.S. Army Health Clinic in Vicenza, Italy. The contract requires the contractor to provide, install, and maintain the analyzer, along with supplying necessary reagents and materials for hematology testing, with an ordering period from May 1, 2025, to September 30, 2029, and a minimum contract value of $1,000. This procurement is critical for enhancing healthcare capabilities at the clinic, ensuring compliance with federal regulations, including HIPAA, and maintaining patient confidentiality. Interested parties, particularly small businesses, service-disabled veteran-owned, and women-owned enterprises, should contact Elena Raspitha at elena.m.raspitha.civ@health.mil for further details.
    Blood Sample Testing
    Buyer not available
    The Department of Defense, through the Defense Health Agency (DHA), is seeking qualified vendors to provide blood sample testing services at Camp Lejeune, North Carolina. This procurement aims to ensure accurate and timely hematological testing, which is critical for the health and readiness of military personnel. The selected contractor will be responsible for conducting various blood tests in accordance with established medical standards. Interested parties should reach out to Gerrie Johnson at gerrie.m.johnson.civ@health.mil for further details regarding the procurement process.
    Reference Laboratory Testing Services for the Landstuhl Regional Medical Center (LRMC), Germany
    Buyer not available
    The Department of Defense, through the Department of the Army, is seeking qualified contractors to provide Reference Laboratory Testing Services for the Landstuhl Regional Medical Center (LRMC) in Germany. The procurement aims to ensure compliance with College of American Pathologists (CAP) standards while delivering a wide range of laboratory tests, including timely reporting of results within 72 hours of specimen receipt. This contract is crucial for maintaining high-quality healthcare services for U.S. military personnel and their families stationed in Europe. Interested parties should contact Henning Mayer-Goldstein at henningfalk.mayer-goldstein.ln@health.mil or Matthew R. Elden at matthew.r.elden.civ@health.mil for further details, with the contract period set from May 2025 to April 2026.
    Microbiological Identification/Susceptibility (ID/AST) testing support for the Landstuhl Regional Medical Center (LRMC), Germany
    Buyer not available
    The Department of Defense, through the Department of the Army, is seeking contractors to provide microbiological identification and susceptibility testing support for the Landstuhl Regional Medical Center (LRMC) in Germany. The procurement involves a five-year contract for the delivery, installation, maintenance, and repair of an Organism Sensitivity and Identification System, along with necessary reagents and supplies, adhering to Clinical Laboratory Improvement Amendments guidelines. This testing support is crucial for ensuring accurate diagnostics and effective treatment protocols within military medical facilities. Interested contractors should contact Henning Mayer-Goldstein at henningfalk.mayer-goldstein.ln@health.mil or Matthew R. Elden at matthew.r.elden.civ@health.mil for further details, and must comply with the submission requirements outlined in the solicitation documents, with deadlines specified in the amendment.
    6550--Lab Testing Services - (HIV/HCV/HPV/On)
    Buyer not available
    The Department of Veterans Affairs is seeking to negotiate a sole-source contract with Roche Diagnostics Corporation for lab testing services related to HIV, HCV, and HPV at the Corporal Michael J. Crescenz VA Medical Center. The contractor will be responsible for providing FDA-approved laboratory systems, instruments, maintenance, and consumables necessary for clinical testing, including a fully automated PCR testing platform with advanced features for real-time detection and minimal maintenance. This procurement is crucial for ensuring the delivery of quality healthcare services to veterans through efficient laboratory solutions. Interested parties must express their interest or submit capabilities by February 13, 2025, and can contact Contract Specialist Yazmin Alvarez at yazmin.alvarez@va.gov or 302-944-2511 x5202 for further information.
    Oncology breast testing
    Buyer not available
    The Department of Defense, through the Defense Health Agency (DHA), is seeking sources for oncology breast testing services. This procurement aims to identify qualified medical laboratories capable of providing specialized testing services critical for cancer diagnosis and treatment. The services will be performed in Bethesda, Maryland, and are essential for supporting the health and readiness of military personnel and their families. Interested parties can reach out to Edgar DuChemin at edgar.r.duchemin.civ@health.mil or call 703-275-6348 for further information regarding this opportunity.
    Q301--Biodesix, Inc. (621 II) (PENDING PROPOSAL)
    Buyer not available
    The Department of Veterans Affairs is soliciting proposals for reference laboratory services under the Federal Supply Schedule (FSS) program, specifically for medical laboratory testing related to disease diagnosis and patient health assessment. The procurement aims to establish contracts for services that comply with federal, state, and local regulations, including necessary licensing and accreditation, while ensuring that only new items are provided and that grey market goods are strictly prohibited. This opportunity is critical for enhancing the quality of healthcare services provided to veterans, with a focus on compliance with the Trade Agreements Act and other regulatory requirements. Interested vendors should contact Contract Specialist Brian O'Connell at Brian.O'connell@va.gov for further details, and they must adhere to the submission deadlines outlined in the solicitation documents.
    vitro diagnostic substances, reagents, test kits and sets
    Buyer not available
    The Department of Defense, through the Naval Medical Research Center, is seeking proposals for a Women-Owned Small Business (WOSB) contract focused on procuring in-vitro diagnostic substances, reagents, and test kits, specifically targeting Biofire Defense products. This procurement is critical for developing reagents used in biological defense against warfare agents, with a total contract value of $64,978.00 for the unique 10x Buffer with BSA 50mM Mg2Cl2, which is essential for operational effectiveness. Interested vendors must submit their offers by March 8, 2025, at 2:00 PM local time, and can direct inquiries to Deborah Sharpe at deborah.m.sharpe2.civ@health.mil or 301-319-9948.
    Blood Coagulation Analyzer
    Buyer not available
    The Department of Defense, through the Medical Readiness Contracting Office - East, is seeking proposals for a firm fixed-price contract to provide a Blood Coagulation Analyzer and associated hemostasis automation systems at Womack Army Medical Center in Fort Liberty, North Carolina. The contractor will be responsible for delivering two analyzers, necessary peripherals, and support services, including installation, training, and maintenance, over a contract period from May 1, 2024, to July 31, 2030. This procurement is critical for ensuring reliable laboratory services that support patient care in a military healthcare environment, adhering to safety and regulatory standards. Interested vendors must be registered with the System for Award Management (SAM) and can direct inquiries to Victoria Manigault or Michael J. McCollum via their respective emails.
    6640--FY25 Q3 Micro Molecular Testing (VA-25-00029953)
    Buyer not available
    The Department of Veterans Affairs (VA) is issuing a presolicitation notice for the procurement of Micro Molecular Testing supplies for the West Palm Beach VA Hospital, under Solicitation No. 36C24825Q0395. The procurement includes various laboratory items and equipment, such as testing kits and the leasing of laboratory instruments, with a requirement for vendors to be Authorized Distributors and provide proof of their status. This initiative is part of the VA's commitment to enhancing its laboratory capabilities to effectively serve veterans. Interested vendors must submit their quotations via email by March 12, 2025, at 2:00 PM Eastern Time, and are encouraged to stay updated on any changes to the solicitation through the Beta-Sam website. For further inquiries, vendors can contact Contract Officer David Henry at David.Henry3@va.gov or by phone at 561-631-3352.